Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Thorax
|
August 21, 2021
CHK yourself, before you wreck yourself: targeting the DNA damage response in secondary pulmonary hypertension
Andrew Bryant, Vinicio de Jesus Perez
American Journal of Respiratory and Critical Care Medicine
|
August 2, 2018
Pulmonary Vascular Complications of Liver Disease
Katrina Lam, Vinicio de Jesus Perez
Stem Cell Investigation
|
July 21, 2017
Inducible pluripotent stem cells and pulmonary arterial hypertension: the future is now!
Monica Romero Lopez, Vinicio de Jesus Perez
Pulmonary Circulation
|
May 4, 2022
Health disparity is a global issue: Understanding Latin America
Mardi Gomberg-Maitland, Vinicio de Jesus Perez
Pulmonary Circulation
|
February 15, 2023
The social and economic disadvantage in pulmonary hypertension: A work (still) in progress
Roberto J Bernardo, Vinicio de Jesus Perez
JAMA Health Forum
|
October 11, 2022
Prioritizing Equity and Diversity in Academic Medicine Faculty Recruitment and Retention
Antonette A Ajayi, Fatima Rodriguez, Vinicio de Jesus Perez
F1000Research
|
December 20, 2016
Recent advances in the management of pulmonary arterial hypertension
Halley Tsai, Yon K Sung, Vinicio de Jesus Perez
FEBS Letters
|
January 21, 2016
PDGF-dependent β-catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension
Jack Takahashi, Mark Orcholski, Ke Yuan, et al.
Frontiers in Medicine
|
October 25, 2024
Unraveling the role of HIF and epigenetic regulation in pulmonary arterial hypertension: implications for clinical research and its therapeutic approach
Ankita Mitra, Dan Yi, Zhiyu Dai, et al.
Current Opinion in Pulmonary Medicine
|
July 24, 2018
Methamphetamine and the risk of pulmonary arterial hypertension
Ramon L Ramirez, Vinicio De Jesus Perez, Roham T Zamanian
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Thorax
|
August 21, 2021
CHK yourself, before you wreck yourself: targeting the DNA damage response in secondary pulmonary hypertension
Andrew Bryant, Vinicio de Jesus Perez
American Journal of Respiratory and Critical Care Medicine
|
August 2, 2018
Pulmonary Vascular Complications of Liver Disease
Katrina Lam, Vinicio de Jesus Perez
Stem Cell Investigation
|
July 21, 2017
Inducible pluripotent stem cells and pulmonary arterial hypertension: the future is now!
Monica Romero Lopez, Vinicio de Jesus Perez
Pulmonary Circulation
|
May 4, 2022
Health disparity is a global issue: Understanding Latin America
Mardi Gomberg-Maitland, Vinicio de Jesus Perez
Pulmonary Circulation
|
February 15, 2023
The social and economic disadvantage in pulmonary hypertension: A work (still) in progress
Roberto J Bernardo, Vinicio de Jesus Perez
JAMA Health Forum
|
October 11, 2022
Prioritizing Equity and Diversity in Academic Medicine Faculty Recruitment and Retention
Antonette A Ajayi, Fatima Rodriguez, Vinicio de Jesus Perez
F1000Research
|
December 20, 2016
Recent advances in the management of pulmonary arterial hypertension
Halley Tsai, Yon K Sung, Vinicio de Jesus Perez
FEBS Letters
|
January 21, 2016
PDGF-dependent β-catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension
Jack Takahashi, Mark Orcholski, Ke Yuan, et al.
Frontiers in Medicine
|
October 25, 2024
Unraveling the role of HIF and epigenetic regulation in pulmonary arterial hypertension: implications for clinical research and its therapeutic approach
Ankita Mitra, Dan Yi, Zhiyu Dai, et al.
Current Opinion in Pulmonary Medicine
|
July 24, 2018
Methamphetamine and the risk of pulmonary arterial hypertension
Ramon L Ramirez, Vinicio De Jesus Perez, Roham T Zamanian
Page
of 8